The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

The World Health Organization is now recommending GLP-1 drugs for adults trying to manage obesity. "Critically endangered" ...

WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...

On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new ...

Obesity remains a pressing global health challenge and was linked to 3.7 million deaths in 2024. - Kenya breaking news | Kenya news today | Capitalfm.co.ke ...

Ozempic-style medications have been endorsed as long-term treatments for obesity under new guidelines released by the World ...

To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health ...

The World Health Organization (WHO) has made a significant recommendation regarding the use of weight loss drugs like Wegovy ...

The WHO has released new guidelines on GLP-1 therapies for obesity, emphasising long-term care, lifestyle changes, and global access to treatments.

WHO issues conditional guidance on GLP‑1 therapies for obesity, calling for wider access amid high prices, safety questions & ...